Baxter International, Inc.

907 articles with Baxter International, Inc.

• Baxter to Host 2022 Investor Conference

  5/10/2022

  Baxter International Inc. (NYSE:BAX), a global medtech leader, will host an investor conference on Wednesday, May 25, 2022 in Glenview, Ill.

• Baxter Increases Dividend and Declares Quarterly Dividend - May 03, 2022

  5/3/2022

  Baxter International Inc., a leading global medtech company, announced an increase in the company’s quarterly cash dividend to a rate of $0.29 per share of common stock.

• Baxter Reports First-Quarter 2022 Results

  4/28/2022

  Baxter International Inc., a global medtech leader, reported results for the first quarter of 2022.

• Baxter Highlights New Data at SCCM Critical Care Congress Showing Hemodynamic Monitoring May Help Predict Patient Outcomes

  4/19/2022

  Baxter International Inc. (NYSE:BAX), a leader in patient monitoring, physical assessment and vision screening products, announced the findings of an observational study on data from the Starling Registry.

• Baxter Announces U.S. FDA Clearance of ST Set Used to Help Treat Acute Kidney Injury Patients in the Hospital

  4/5/2022

  Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ST Set used in continuous renal replacement therapy (CRRT).

• Baxter to Host First-Quarter 2022 Financial Results Conference Call for Investors

  3/23/2022

  Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2022 financial results on Thursday, April 28, 2022 at 7:30 a.m. Central Time.

• Baxter Presents Data Indicating Sharesource Increases Patients’ Time on Home Dialysis by More Than Three Months

  3/1/2022

  Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, announced today new data indicating the use of Baxter’s Sharesource remote patient management platform with an automated peritoneal dialysis (APD) cycler may improve the clinical effectiveness of home kidney patients care by extending their time on therapy by 3.4 months.

• Baxter to Present at the Raymond James 43rd Annual Institutional Investors Conference

  2/22/2022

  Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James 43rd Annual Institutional Investors Conference on Monday, March 7, 2022. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Eastern Time.

• 

  Newsweek’s Most Responsible Companies are BioSpace’s Best Places to Work

  2/18/2022

  BioSpace compared the 43 healthcare and life science companies on Newsweek's list of America’s Most Responsible Companies for 2022 with that of our own 2022 Best Places to Work.

• Baxter Reports Fourth-Quarter and Full-Year 2021 Results

  2/17/2022

  Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2021, and provided its financial guidance for full-year and first-quarter 2022.

• Baxter Declares Quarterly Dividend - Feb 14, 2022

  2/14/2022

  Baxter International Inc., a global medtech leader, announced that its Board of Directors has declared a quarterly cash dividend of $0.28 per share of common stock.

• Baxter to Present at Citi’s 2022 Virtual Healthcare Conference

  2/10/2022

  Baxter International Inc., a global medtech leader, will present at Citi’s 2022 Virtual Healthcare Conference on Wednesday, February 23, 2022.

• Medically Home Announces a $110 Million Strategic Investment Led by Baxter International Inc., Global Medical Response and Cardinal Health to Advance Leadership in Hospital-Level Patient Care at Home

  1/10/2022

  Medically Home announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global Medical Response and Cardinal Health who will each have representation on the company's Board.

• Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors

  1/6/2022

  Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2021 financial results on Thursday, February 17, 2022 at 7:30 a.m. Central Time.

• 

  Incoming CEO Andy Kidd Prepares to Take Aptinyx to the Next Level

  1/4/2022

  Right now, Kidd’s focus is on ensuring the company is ready for late-stage development and commercialization activities.

• Baxter Completes Acquisition of Hillrom, Creating ~$15 Billion Global Medtech Leader

  12/13/2021

  Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today it has completed its acquisition of Hillrom.

• Baxter Presents Data at ASHP Meeting Indicating Machine Learning May Enhance Infusion Pump Programming Safety

  12/8/2021

  Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, announced new data from a retrospective study finding that machine learning, a type of artificial intelligence (AI) that uses algorithms to find patterns in large amounts of data, may help support clinical decision-making during the programming of smart infusion pumps.

• Hillrom Shareholders Approve Acquisition By Baxter

  12/2/2021

  Hillrom announced that its shareholders have voted to approve the previously announced pending acquisition by Baxter International Inc. at a special meeting.

• Baxter Declares Quarterly Dividend - Nov 16, 2021

  11/16/2021

  Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products.

• Baxter Announces $100 Million Investment in BioPharma Solutions Halle/Westfalen, Germany Sterile Fill/Finish Manufacturing Facility

  11/11/2021

  Baxter International Inc., a global leader in sterile medication production and delivery, announced an approximately $100 million expansion of its sterile fill/finish manufacturing facility located in Halle/Westfalen, Germany.